Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994.
(1995) Acta Clinica Belgica (Multilingual Edition) — Vol. 50, n° 2, p. 114-116 (1995)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- Due to the growing incidence and the severity of infections due to vancomycin resistant enterococci, it is now recommended to treat mild to moderate cases of Clostridium difficile-associated diarrhoea with metronidazole while maintaining the use of oral vancomycin in serious or life-threatening colitis. Clostridium difficile is a common cause of diarrhoea after antibiotic therapy and induces a spectrum of diseases ranging from mild diarrhoea to pseudomembranous colitis (PMC). It is considered to be the first cause of diarrhoea occurring among hospitalized patients (1).
- Affiliations
Citations
Delmée, M., Melin, P., Peetermans, W., Verbist, L., & Verschraegen, G. (1995). Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994. Acta Clinica Belgica (Multilingual Edition), 50(2), 114-116. https://hdl.handle.net/2078.5/72229 (Original work published 1995)